Amoytop Acquires Skyline To Kickstart China 2025 M&A Activity

 
• By Dexter Jie Yan
  
Xiamen Amoytop Biotech has announced the first acquisition between Chinese biopharmas and pre-revenue biotechs in years. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Business